Welcome to our dedicated page for Dentsply Sirona news (Ticker: XRAY), a resource for investors and traders seeking the latest updates and insights on Dentsply Sirona stock.
Dentsply Sirona Inc. (Nasdaq: XRAY), a global innovator in dental technologies and oral health solutions, provides this dedicated news hub for stakeholders tracking its market activities. Access real-time updates on earnings reports, product launches, regulatory milestones, and strategic partnerships shaping the dental industry.
This resource consolidates official press releases and verified news to help investors and professionals stay informed about XRAY developments. Key updates include innovations in CAD/CAM systems, digital imaging advancements, and global distribution initiatives.
Bookmark this page for streamlined access to critical updates impacting dental practices and investment decisions. Regular visitors gain timely insights into how Dentsply Sirona maintains its leadership through technological excellence and operational execution.
Dentsply Sirona (NASDAQ: XRAY) reported Q2 2024 results with net sales of $984 million, down 4.2% year-over-year. The company experienced a net loss of $4 million or ($0.02) per share, compared to net income of $86 million in Q2 2023. Adjusted EPS was $0.49, down from $0.51 in the previous year.
Key highlights include:
- Organic sales decreased by 2.3%
- GAAP gross margin of 51.9%
- Adjusted EBITDA margin of 17.5%
- $150 million in share repurchases during Q2
Dentsply Sirona revised its FY24 outlook, now expecting organic sales to be down 1% to flat, and adjusted EPS between $1.96 and $2.02. The company also announced a second phase of transformation, aiming to reduce annualized operating expenses by $80 to $100 million over 12 to 18 months.
Dentsply Sirona (Nasdaq: XRAY) will host an investor conference call and live webcast on July 31, 2024, at 8:30 am ET to discuss its second-quarter financial results. The presentation will be accessible on the company's investor site. Interested participants can register for the call via a provided link, and a replay will be available post-event.
Dentsply Sirona (Nasdaq: XRAY) has canceled its participation in the Goldman Sachs 45th Annual Global Healthcare Conference due to weather-related flight disruptions.
The company was initially scheduled to take part on June 13, 2024, at 8:00 am ET.
Dentsply Sirona (Nasdaq: XRAY) has announced its participation in two upcoming investor conferences. The company will present at the William Blair 44th Annual Growth Stock Conference on June 5, 2024, at 9:20 am CT and the Goldman Sachs 45th Annual Global Healthcare Conference on June 13, 2024, at 8:00 am ET. Interested parties can access live and replay webcasts via the Dentsply Sirona investor website.
Dentsply Sirona, trading under the Nasdaq symbol XRAY, announced that its Board of Directors has declared a quarterly cash dividend of $0.16 per share of common stock.
This equates to an annual rate of $0.64 per share. The dividend is scheduled to be paid on July 12, 2024, to shareholders who are on record as of June 28, 2024.
Dentsply Sirona Inc. (XRAY) will participate in the Bank of America 2024 Health Care Conference on May 15, 2024, and the Stifel 2024 Jaws and Paws Conference on May 29, 2024. Investors can access live audio webcasts on the company's website.
Dentsply Sirona reported a decrease in net sales of 2.6% in the first quarter of 2024, with organic sales down 1.9%. The GAAP gross margin was 53.1%, with net income of $18 million or $0.09 per share. Adjusted EBITDA margin was 16.8%, with adjusted EPS of $0.42. The company is maintaining its FY24 outlook but trending towards the low-end of both organic sales and adjusted EPS ranges. Dentsply Sirona plans to repurchase up to $150 million of its common stock in Q2 2024.
FAQ
What is the current stock price of Dentsply Sirona (XRAY)?
What is the market cap of Dentsply Sirona (XRAY)?
